Anthony Bosch, founder of former South Florida anti-aging clinic Biogenesis, has admitted to injecting performance-enhancing drugs (PEDs) into the New York Yankees third baseman, Alex Rodriguez.
Bosch told CBS's "60 Minutes" he and Rodriguez scheduled specific times in which PEDs would be injected.
He also disclosed that he went as far as to meet Rodriguez in the bathroom stall of a Miami nightclub to inject the drugs.
The doping guru explained in detail minute-to- minute regimen of performance-enhancing substances he delivered to the disgraced baseball star.
Included were concoctions called gummies, liquid soap, pink cream, blue cream, and even PM cream-each with varying doses of testosterone delivered in different ways throughout the day.
Bosch was paid USD12, 000 a month for the PEDs he supplied to Rodriguez.
US Anti-Doping Agency CEO Travis Tygart said Bosch's regimen included dozens of blood tests to see how the drugs were metabolising and which doses to use when.
News.com.au quoted Tygart, as saying that a potent cocktail of sophisticated PEDs stacked together to deliver power, aid recovery, avoid detection and create a home run champion.
Bosch faces potential charges stemming from the investigation into his Biogenesis clinic in south Florida.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
